MAIA MAIA Biotechnology, Inc.
$1.17▲ +5.41%
Healthcare
Other
After hours
$1.16▼ -0.74%
Oct 27, 5:31 PM ET
Volume 300.6K
Avg Volume (10D) 316.9K
Key Metrics & Fundamentals
Market Cap
$72.24M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.87 - 3.19
% vs 50 MA
-7.05%
% vs 200 MA
-20.20%
RSI-14
48.7
MACD Histogram
+0.0100
Beta (1Y vs SPY)
1.57
Free Cash Flow
-$6.75M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$8.04M
COGS
–
Operating Exp
$8.11M
Operating Income
-$8.11M
EBIT
-$8.11M
Pretax Income
-$7.94M
Net Income
-$7.94M
EPS (Diluted)
-0.13
Price & Volume History
Loading chart…
Recent News
MAIA Biotechnology Achieves Patient Enrollment Milestones in Ongoing Phase 2 and Pivotal Phase 3 Clinical Trials in Non-Small Cell Lung Cancer
GlobeNewswire · Oct 7, 2026 8:15 AM ET
Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA)
GlobeNewswire · Oct 1, 2026 8:00 AM ET
MAIA Biotechnology Expands Pivotal Phase 3 THIO-104 Non-Small Cell Lung Cancer Trial into Spain and Portugal
GlobeNewswire · Sep 23, 2026 9:17 AM ET
MAIA Biotechnology Reports Pivotal Phase 3 Clinical Trial Progress in Advanced Non-Small Cell Lung Cancer
GlobeNewswire · Sep 22, 2026 8:47 AM ET
MAIA Biotechnology Doses First U.S. Patient in Ongoing Phase 2 Non-Small Cell Lung Cancer Clinical Trial
GlobeNewswire · Sep 16, 2026 8:15 AM ET
MAIA Biotechnology Announces Open Market Purchases of Company Stock by Long-Standing Board Member and CEO
GlobeNewswire · Sep 15, 2026 8:15 AM ET
MAIA Biotechnology Delivers Oral and Poster Presentations Showcasing Next-Generation Telomere-Targeting Cancer Therapies at IRT 2026
GlobeNewswire · Sep 10, 2026 8:15 AM ET
Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA)
GlobeNewswire · Aug 17, 2026 8:00 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See MAIA's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.